A Study of Injectable BLB101 and Blincyto® in Adult Participants With R/R CD19+ B-ALL
A Study of Injectable BLB101 and Blincyto® in Adult Participants With R/R CD19+ B-ALL
Not yet recruiting · NCT07723911 · Registry updated 2026-07-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Injectable BLB101 and Blincyto® in Adult Participants With R/R CD19+ B-ALL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm, precursor B-cell acute lymphoblastic leukemia | Not yet recruiting | Phase 3 | 2026-07-23 | NCT07723911 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 285 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||